🔎 Trials Near Me

Dachaigh › Galaran tiroid › Texas › Houston

Sgrùdaidhean clionaigeach Galaran tiroid ann an Houston, TX

Tha 5 sgrùdaidhean airson Galaran tiroid a’ lorg phàirtichean aig làraichean ann agus timcheall air Houston (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

A’ fastadhÌre 1
  • MD Anderson, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT04913285

Study of BHV-1300 in Graves' Disease

A’ fastadhÌre 1
  • Site-106, Houston
  • Site-101, Houston
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 31 Iuch 2026 · NCT06980649

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

A’ fastadhÌre 1/2
  • MD Anderson Cancer Center, Houston
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 27 Cèit 2026 · NCT03093116

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

A’ fastadhÌre 2/3
  • Juno Research /ID# 259238, Houston
  • Biopharma Informatic - Houston - Business Center Drive /ID# 256149, Houston
  • PlanIt Research, PLLC /ID# 259221, Houston
  • agus 1 a bharrachd
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 5 Faoi 2026 · NCT06345339

Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease

A’ fastadhSgrùdadh amharc
  • University of Texas MD Anderson Cancer Center, Houston
Gach aois · Gach gnè · Air ùrachadh 17 Sult 2019 · NCT03050762

Sgrùdaidhean Galaran tiroid ann am bailtean eile

Sgrùdaidhean eile ann an Houston

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.